The AR-ADAR2-PD-L1 Axis as a Prognostic Biomarker System in BCG-Treated High-Grade Papillary Urothelial Carcinoma: A Single-Center Retrospective Cohort Study
Oncology Research · Gabriele Ricciardi, Mariagiovanna Ballato, Pietro Tralongo et al. · 2026
- EnglishRead in your language
- CitedEvery fact sourced
- Ad-freeNo ads, no tracking
Quick facts
Questions
- Who wrote The AR-ADAR2-PD-L1 Axis as a Prognostic Biomarker System in BCG-Treated High-Grade Papillary Urothelial Carcinoma: A Single-Center Retrospective Cohort Study?
- The AR-ADAR2-PD-L1 Axis as a Prognostic Biomarker System in BCG-Treated High-Grade Papillary Urothelial Carcinoma: A Single-Center Retrospective Cohort Study was written by Gabriele Ricciardi, Mariagiovanna Ballato, Pietro Tralongo, Marta Rossanese.
- When was The AR-ADAR2-PD-L1 Axis as a Prognostic Biomarker System in BCG-Treated High-Grade Papillary Urothelial Carcinoma: A Single-Center Retrospective Cohort Study first published?
- The AR-ADAR2-PD-L1 Axis as a Prognostic Biomarker System in BCG-Treated High-Grade Papillary Urothelial Carcinoma: A Single-Center Retrospective Cohort Study was first published in 2026.
Sources
Last updated · facts checked 2 November 2026
Cite this page
"The AR-ADAR2-PD-L1 Axis as a Prognostic Biomarker System in BCG-Treated High-Grade Papillary Urothelial Carcinoma: A Single-Center Retrospective Cohort Study". DigiNepal. Last updated 2 October 2026. https://diginpl.com/books/paper-or-2026-086237. Retrieved 14 November 2026.
Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.086237.